treatment

SORAFENIB IN HCC: REAL CLINICAL PRACTICE. LITERATURE REVIEW

от

I.I. Abdullin1, K.V. Menshikov1,2, A.V. Sultanbaev1,2, E.V. Popova1, O.N. Lipatov2 1Republican Clinical Oncology Dispensary, Ufa 2Bashkir State Medical University, Ufa Abdullin Ilyas I. ― oncologist of the outpatient antitumor drug therapy department of the Republican Clinical Oncology Dispensary 73/1 Oktyabrya Ave., Ufa, 450054, Russian Federation, e-mail: ilyas.abdullin.99@mail.ru, ORCID ID: 0009-0009-8470-4606 Abstract. Currently, sorafenib is a … Читать далее

MEDULLARY THYROID CANCER. FEATURES OF DIAGNOSIS AND TREATMENT

от

V.V. Skvortsov, M.Yu. Vlasov Volgograd State Medical University, Volgograd  Skvortsov V.V. ― D. Med. Sc., Associate Professor of the Department of Propaedeutics of Internal Diseases of the Volgograd State Medical University 1 Pavshikh Bortsov Sq., Volgograd, 400131, Russian Federation, tel. (8442) 37-26-92  Abstract. Medullary thyroid cancer is a rare hormonal-active malignant thyroid tumor that originates … Читать далее